FinancialPerformanceforǫ4&FullYearFY25
20th May 2025, Ahmedabad, India
- The audited results were taken on record by the Board of Directors at a meeting held today. The Board recommended a dividend of 1100%.
ǫ4FY25
- Revenue from operations at Rs. 65,279 mn, up 18% over last year.
- Research & Development (R&D) investments for the quarter stood at Rs. 4,799 mn (7.4% of revenues).
- EBITDA for the quarter was Rs. 21,255 mn, up 30% YoY. EBITDA margin for the quarter stood at 32.6%, which is an improvement of 310 bps on a YoY basis.
- Net Profit, adjusted for exceptional items, was Rs. 13,905 mn, up 18% YoY.
- Capex (organic) for the quarter was Rs. 3,202 mn.
FullYearFY25
- Revenue from operations at Rs. 2,32,415 mn, up 19% over last year.
- Research & Development (R&D) investments for the year stood at Rs. 18,555 mn (8.0% of revenues).
- EBITDA for the year was Rs. 70,585 mn, up 31% YoY. EBITDA margin for the year stood at 30.4%, which is an improvement of 290 bps over the previous year.
- Net Profit, adjusted for exceptional items, was Rs. 47,451 mn, up 23% YoY.
- Capex (organic) for the full year was Rs. 12,140 mn.
- Net Debt to Equity ratio as on 31st March, 2025 was -0.20x while Net Debt to EBITDA stood at -0.69x at the end of March, 2025. Net Cash (negative Net Debt) as on March 31st, 2025 was Rs. 48,836 mn.
| Rs.mn | ǫ4 FY25 | ǫ4 FY24 | %Gr. y-o-y | ǫ3 FY25 | %Gr. q-o-q |
| Revenue from Operations | 65,279 | 55,338 | 18.0% | 52,691 | 23.9% |
| EBITDA | 21,255 | 16,305 | 30.4% | 13,876 | 53.2% |
| EBITDA margin (%) | 32.6% | 29.5% | 26.3% | ||
| PBT1 | 18.916 | 15,470 | 22.3% | 11,841 | 59.8% |
| Net Profit1 | 13,905 | 11,823 | 17.6% | 10,235 | 35.9% |
| Net Profit (Reported) | 11,709 | 11,823 | -1.0% | 10.235 | 14.4% |
| Rs.mn | FY25 | FY24 | %Gr. y-o-y |
| Revenue from Operations | 2,32,415 | 1,95,474 | 18.9% |
| EBITDA | 70,585 | 53,843 | 31.1% |
| EBITDA margin (%) | 30.4% | 27.5% | |
| PBT1,2 | 62,463 | 48,231 | 29.5% |
| Net Profit1,2 | 47,451 | 38,737 | 22.5% |
| Net Profit (Reported) | 45,255 | 38,595 | 17.3% |
Notes:
- Adjusted for impairment charge on Goodwill and Technical Know-how of Rs. 2,196 mn in ǫ4 and full year FY25.
- Adjusted for expenses incurred in connection with cessation of operations of one of the manufacturing facilities of Zydus Wellness Products Ltd (ZWPL) of Rs. 177 mn and gain on sale of assets by ZWPL which were classified as “Assets held for sale” of Rs. 35 mn.
